Skip to content

    IOVANCE BIOTHERAPEUTICS (IOVA) stock price & financials

    View IOVA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+231.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $58.55M
    $73.69M
    $49.32M
    $59.95M
    $67.45M
    +15.2%
    $86.77M
    +17.7%
    $71.43M
    +44.8%
    $99.31M
    +65.7%
    Strengthening
    Operating Profit
    -$89.07M
    -$86.58M
    -$121.22M
    -$113.77M
    -$94.90M
    -6.6%
    -$73.46M
    +15.1%
    -$81.04M
    +33.1%
    -$51.91M
    +54.4%
    Strengthening
    Net Profit
    -$83.54M
    -$78.56M
    -$116.16M
    -$111.66M
    -$91.25M
    -9.2%
    -$71.90M
    +8.5%
    -$79.05M
    +32.0%
    -$47.31M
    +57.6%
    Strengthening
    EPS
    $-0.28
    $-0.36
    $-0.33
    $-0.25
    +10.7%
    $-0.19
    +47.2%
    $-0.11
    +66.7%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$85.06M
    -$77.00M
    -$118.00M
    -$109.67M
    -$93.66M
    -10.1%
    -$71.72M
    +6.9%
    -$79.71M
    +32.4%
    -$48.69M
    +55.6%
    Strengthening
    MarginsOPM
    -152.1%
    -117.5%
    -245.8%
    -189.8%
    -140.7%
    +7.5%
    -84.7%
    +27.9%
    -113.5%
    +53.8%
    -52.3%
    +72.5%
    Strengthening
    Tax
    1.8%
    -2.0%
    1.6%
    -1.8%
    2.6%
    +43.6%
    -0.3%
    +87.1%
    0.8%
    -46.8%
    2.8%
    Strengthening
    ReturnsROIC
    2.9%
    2.7%
    4.0%
    3.8%
    3.1%
    +9.2%
    2.5%
    -8.5%
    2.7%
    -32.0%
    1.6%
    -57.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$82.15M$13.97M$67.33M$78.23M$231.73M$114.89M$115.69M$163.08M$110.77M
    Short-Term Investments
    Total Current Assets$475.37M$316.49M$636.10M$507.96M$479.12M$307.85M$457.02M$442.69M$464.26M
    Net PP&E$2.68M$19.23M$113.92M$169.92M$178.25M$176.54M$164.28M$177.01M$174.94M
    Goodwill
    Intangibles$229.26M$282.40M$279.32M$263.89M
    Total Assets$480.82M$344.65M$768.46M$777.33M$663.98M$780.35M$910.43M$913.17M$915.53M
    LiabilitiesTotal Current Liabilities$14.40M$39.08M$54.87M$89.20M$91.48M$110.31M$122.34M$138.36M$106.85M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$4.25M$45.38M$65.47M$71.86M$67.08M$44.37M$44.40M$43.33M
    Total Liabilities$14.63M$45.68M$111.96M$155.67M$164.34M$195.74M$200.02M$214.59M$179.49M
    EquityCommon Stock & APIC$5.0K$5.0K$6.0K$7.0K$8.0K$11.0K$13.0K$17.0K$19.0K
    Retained Earnings-$372.76M-$570.61M-$830.19M-$1.17B-$1.57B-$2.01B-$2.38B-$2.78B-$2.90B
    Total Equity$466.19M$298.97M$656.50M$621.66M$499.64M$584.61M$710.40M$698.58M$736.04M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$101.25M-$158.89M-$205.13M-$227.94M-$292.76M-$361.82M-$352.98M-$302.41M-$264.18M
    Cash from Investing-$386.28M$90.03M-$317.85M$132.0K$256.45M-$155.24M-$96.41M$47.50M-$44.87M
    Cash from Financing$424.31M$6.13M$576.42M$239.27M$190.15M$462.96M$390.66M$300.77M$287.85M
    SummaryCapital Expenditure-$1.20M-$6.92M-$46.79M-$37.57M-$20.43M-$22.29M-$11.07M-$33.84M-$32.21M
    Free Cash Flow-$102.45M-$165.81M-$251.93M-$265.51M-$313.18M-$384.11M-$364.05M-$336.24M-$296.39M
    FCF Margin-32305.3%-221.9%-127.6%-91.2%

    Ratios